kaonavi
4435
Wintest
6721
Allied Telesis Holdings KK
6835
Itamiarts
168A
D. Western Therapeutics Institute
4576
(FY)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -43.82%29.17B | -75.28%2.63B | -51.00%8.96B | -18.68%8.37B | 2.60%51.93B | 12.7B | -23.21%10.65B | 43.72%18.28B | 173.13%10.3B | 172.70%50.61B |
Net profit before non-cash adjustment | -25.73%18.78B | 18.30%3.61B | -5.70%7.33B | -70.68%2.75B | -28.96%25.29B | --5.09B | -76.10%3.06B | -34.89%7.78B | -9.45%9.37B | 18.72%35.6B |
Total adjustment of non-cash items | 20.85%24.01B | 63.60%4.26B | -9.86%8.47B | 92.97%5.35B | -38.19%19.87B | --5.1B | 22.62%2.6B | 4.72%9.39B | 22.60%2.77B | 89.04%32.15B |
-Depreciation and amortization | 9.99%23.98B | 9.67%6.09B | 11.19%5.97B | 12.48%5.79B | 4.65%21.8B | --5.73B | 4.81%5.55B | 4.29%5.37B | 5.06%5.15B | 11.13%20.83B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --13.64B |
-Share of associates | -37.50%-55M | -167.86%-75M | -137.31%-25M | --0 | 92.97%-40M | --82M | 86.54%-28M | 145.27%67M | -15.83%-161M | -58.94%-569M |
-Disposal profit | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Other non-cash items | 104.54%86M | 39.84%-1.76B | -36.28%2.52B | 79.94%-445M | -7.68%-1.89B | ---706M | 1.52%-2.92B | -0.33%3.96B | 11.39%-2.22B | -27.02%-1.76B |
Changes in working capital | -301.26%-13.62B | -204.97%-5.24B | -714.65%-6.84B | 115.01%277M | 139.51%6.77B | --2.51B | 581.76%4.99B | 113.59%1.11B | 79.12%-1.85B | 39.74%-17.13B |
-Change in receivables | -102.59%-570M | -89.60%920M | -63.49%2.62B | -346.85%-5.13B | 332.41%22.04B | --3.93B | 702.54%8.84B | 201.20%7.19B | 155.72%2.08B | 61.92%-9.48B |
-Change in inventory | -413.92%-5.39B | -5,059.41%-5.01B | 131.40%276M | 76.05%-617M | 89.20%-1.05B | --2.31B | 102.75%101M | -56.41%-879M | 48.74%-2.58B | 31.57%-9.71B |
-Change in payables | 50.72%-6.81B | 73.44%-1.01B | -90.51%-9.58B | 640.42%6.23B | -657.45%-13.81B | ---3.82B | -329.48%-3.81B | -1,047.49%-5.03B | -2,360.78%-1.15B | -76.63%2.48B |
-Changes in other current assets | -109.54%-857M | 2.14%-137M | 1.78%-166M | -4.59%-205M | 0.97%-409M | --96M | -13.82%-140M | -87.78%-169M | -45.19%-196M | -755.56%-413M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -12.89%-473M | 19.66%-94M | -13.91%-131M | -37.89%-131M | -26.59%-419M | -92M | -108.93%-117M | -3.60%-115M | -21.79%-95M | -2.80%-331M |
Interest received (cash flow from operating activities) | 19.18%2.89B | 14.44%721M | 42.21%812M | 36.13%682M | 118.58%2.42B | 722M | 145.14%630M | 173.21%571M | 154.31%501M | 78.30%1.11B |
Tax refund paid | 78.26%-3.17B | 71.89%-1.46B | 138.84%632M | 89.83%-679M | -5.56%-14.6B | -1.11B | -14.31%-5.18B | -101.36%-1.63B | 5.56%-6.68B | -330.04%-13.83B |
Other operating cash inflow (outflow) | 50.00%-1M | 150.00%1M | 0 | 0.00%-2M | -2M | 1M | 33.33%-2M | 1M | -2M | 0 |
Operating cash flow | -27.76%28.41B | -69.82%1.8B | -39.98%10.27B | 104.97%8.24B | 4.71%39.33B | --12.23B | -37.30%5.98B | 42.48%17.11B | 226.36%4.02B | 140.11%37.56B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -8.23%-29.14B | 12.60%-6.09B | -21.46%-6.82B | -15.04%-7.31B | 7.08%-26.92B | ---7.99B | 8.55%-6.96B | 15.37%-5.62B | -1.57%-6.36B | -50.88%-28.97B |
Net business purchase and sale | --13M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | -7.75%238M | -102.96%-11M | 80.77%-10M | -32.99%-129M | 147.69%258M | --36M | 218.53%371M | 42.86%-52M | -234.48%-97M | -285.27%-541M |
Net changes in other investments | -1,135.88%-5.34B | -213.29%-1.34B | -534.18%-2.92B | 9.25%-314M | 23.94%-432M | ---330M | -639.66%-429M | 766.34%673M | -60.93%-346M | -164.19%-568M |
Investing cash flow | -26.31%-34.22B | -5.98%-7.44B | -95.01%-9.74B | -14.06%-7.76B | 9.93%-27.09B | ---8.28B | 12.07%-7.02B | 26.85%-4.99B | -4.57%-6.8B | -57.29%-30.08B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 0.00%-12.19B | --0 | --0 | 0.00%-12.19B | -168.40%-12.19B | --10B | -200.00%-10B | --0 | -457.67%-12.19B | 915.33%17.82B |
Net common stock issuance | -200,900.00%-4.02B | 0.00%-1M | ---1M | --0 | 99.97%-2M | ---1M | 0.00%-1M | --0 | --0 | -17.10%-5.96B |
Increase or decrease of lease financing | -8.38%-2.1B | -15.23%-575M | 6.00%-470M | -10.44%-497M | -0.94%-1.93B | ---485M | -5.05%-499M | -5.49%-500M | 5.26%-450M | -7.34%-1.92B |
Cash dividends paid | 57.46%-4.17B | 38.88%-2.23B | 66.67%-23M | 67.97%-1.94B | -2.22%-9.8B | ---21M | 19.48%-3.66B | 25.00%-69M | -22.82%-6.05B | -168.55%-9.58B |
Cash dividends for minorities | 47.28%-184M | -6,000.00%-183M | 46.36%-184M | --0 | 54.44%-349M | ---3M | 50.00%-3M | -11.36%-343M | --0 | -681.63%-766M |
Net other fund-raising expenses | ---- | 200.00%1M | --0 | ---2M | 99.97%-1M | --1M | -200.00%-1M | ---- | ---- | -324,100.00%-3.24B |
Financing cash flow | 6.65%-22.65B | 78.87%-2.99B | 25.74%-678M | 21.74%-14.62B | -565.00%-24.27B | --9.49B | -384.32%-14.16B | -4.22%-913M | -33.53%-18.69B | 71.32%-3.65B |
Net cash flow | ||||||||||
Beginning cash position | -4.49%156.49B | -3.04%154.79B | 3.45%148.56B | -4.49%156.49B | 8.19%163.84B | --147.05B | 11.79%159.64B | 9.03%143.61B | 8.19%163.84B | -4.66%151.43B |
Current changes in cash | -136.64%-28.46B | 43.24%-8.63B | -101.31%-147M | 34.15%-14.13B | -413.97%-12.03B | --13.44B | -333.03%-15.21B | 160.17%11.2B | 9.36%-21.46B | 123.64%3.83B |
Effect of exchange rate changes | 119.44%10.27B | -507.42%-10.66B | 31.92%6.38B | 404.14%6.21B | -45.41%4.68B | ---4B | -35.76%2.62B | -28.80%4.83B | -68.86%1.23B | -2.57%8.57B |
Cash adjustments other than cash changes | ---- | ---- | ---- | ---1M | -200.00%-1M | ---- | ---- | ---- | ---- | 200.00%1M |
End cash Position | -11.63%138.29B | -7.85%135.51B | -3.04%154.79B | 3.45%148.56B | -4.49%156.49B | --156.49B | -4.14%147.05B | 11.79%159.64B | 9.03%143.61B | 8.19%163.84B |
Free cash flow | -109.37%-1.15B | -360.48%-4.61B | -70.61%3.37B | 138.65%926M | 50.69%12.29B | --4.2B | -154.13%-1B | 116.27%11.48B | 74.90%-2.4B | 326.19%8.15B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |